Ikena Oncology Inc
NASDAQ:IKNA
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
Ikena Oncology Inc
Ikena Oncology Inc
Total Equity
Ikena Oncology Inc
Total Equity Peer Comparison
JNJ
BMY
PFE
MRK
LLY
Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors
| Company | Total Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Ikena Oncology Inc
NASDAQ:IKNA
|
Total Equity
$169.8m
|
CAGR 3-Years
17%
|
CAGR 5-Years
59%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Equity
$70B
|
CAGR 3-Years
2%
|
CAGR 5-Years
3%
|
CAGR 10-Years
-1%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Equity
$16.5B
|
CAGR 3-Years
-24%
|
CAGR 5-Years
2%
|
CAGR 10-Years
1%
|
|
|
Pfizer Inc
NYSE:PFE
|
Total Equity
$92.3B
|
CAGR 3-Years
10%
|
CAGR 5-Years
9%
|
CAGR 10-Years
2%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Total Equity
$40.4B
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-2%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Equity
$12.8B
|
CAGR 3-Years
23%
|
CAGR 5-Years
39%
|
CAGR 10-Years
-4%
|
See Also
What is Ikena Oncology Inc's Total Equity?
Total Equity
169.8m
USD
Based on the financial report for Dec 31, 2023, Ikena Oncology Inc's Total Equity amounts to 169.8m USD.
What is Ikena Oncology Inc's Total Equity growth rate?
Total Equity CAGR 5Y
59%
Over the last year, the Total Equity growth was 15%. The average annual Total Equity growth rates for Ikena Oncology Inc have been 17% over the past three years , 59% over the past five years .
You don't have any saved screeners yet
